Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Empagliflozin in Post-Transplantation Diabetes Mellitus

NCT03113110 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT03113110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Empagliflozin in Post-Transplantation Diabetes Mellitus
Lead sponsor
Medical University of Vienna
Phase
Phase 2
Overall status
Completed
Start date
January 15, 2017
Completion date
May 31, 2018
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posttransplant diabetes mellitus